Concerns raised about COVID-19 chronic olfactory dysfunction
Nov 19, 2021
“These data suggest an emerging public health concern of OD and the urgent need for research that focuses on treating COVID-19 COD,” the authors wrote.
Immune response not inferior with coadministration of COVID-19, flu shots
Sep 14, 2023
A similar immune response and no increase in the rate of reactogenicity events was seen with coadministration versus administering the COVID-19 vaccine alone.
Fewer deaths reported with enrollment in COVID-19 remote monitoring
Nov 18, 2021
The remote monitoring service, COVID Watch, reduced deaths at 30 and 60 days and was associated with presentation to the emergency department sooner.
COVID-19 infection risk drops with increasing immunity within family
Oct 13, 2021
Risk for COVID-19 infection progressively lower for nonimmune family members as number of family members with immunity increases
Viral rebound uncommon after molnupiravir, nirmatrelvir-ritonavir therapy
Dec 09, 2022
Viral rebound was uncommon with treatment for patients hospitalized with COVID-19 and not associated with increased mortality.
Study confirms virulence of SARS-CoV-2 variants of concern
Oct 05, 2021
The risks for hospitalization, ICU admission, death were up for N501Y-positive variants but were even more pronounced with the delta variant.
Medicare, many third-party insurers to cover coronavirus testing
By
Amy Novotney
Mar 10, 2020
Medicare and several leading insurers have committed to helping mitigate the costs associated with testing for and treating the novel coronavirus that has been spreading nationwide. In addition, officials...
Disinfecting senior living communities during the COVID-19 pandemic
By
Noel McCarthy
Aug 20, 2020
There are things we can do to mitigate the effects of this pandemic. Case in point: Disinfecting our facilities as often as we (practically) can.
Minimal change in mental health linked to COVID-19
Mar 09, 2023
In general population studies, no change was observed in general mental health or anxiety symptoms; minimal worsening was seen in depression symptoms.
Risk for first-time clot events raised after COVID-19 diagnosis
Sep 29, 2022
The incidence is highest in the first week but remains elevated up to 49 weeks after COVID-19 diagnosis.